Found 578 matching trials
Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
N/AThis retrospective cohort study investigates the effects of SGLT2 inhibitor...
Status
Active Not Recruiting
Location
University Medical Centre Ljubljana
Dapagliflozin Efficacy and Action in NASH
PHASE3This is a multicentre, randomized, placebo-controlled trial to assess the e...
Location
Nanfang Hospital of Southern Medical University
SGLT2 Inhibitors in Geographic Atrophy
PHASE2AMD is a leading cause of blindness in individuals over 50 years old, with ...
Location
Washington University
Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction
PHASE2Gliflozins have demonstrated a beneficial effect in terms of incident heart...
Location
Pitié-Salpêtrière Hospital
Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies
N/AARIADNE is a prospective observational cohort study of patients with type 2...
Status
Active Not Recruiting
Location
2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens
STunning in Acute Myocardial Infarction - BAS
PHASE4The objective of this trial is to examine the effect of immediate versus la...
Location
Sahlgrenska University Hospital
The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients
N/AThe objective of this survey is to confirm the safety of Suglat Tablets whe...
Location
Multiple Locations
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
PHASE3Background. Treatment with intravenous iron has been shown to improve sympt...
Location
Hospital de Clínicas de Porto Alegre
Pre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac Surgery: a Retrospective Monocentric Cohort Study
N/ACardiac surgery with cardiopulmonary bypass exposes patients to the risk of...
Location
Hôpital cardiologique Louis Pradel Groupe Hospitalier Est
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
PHASE2Sickle cell anemia (SCA) is an inherited red blood disorder. The kidneys ar...
Location
University of Illinois Chicago, Sickle Cell Center